From: chemistry-request at ccl.net
To: chemistry-request at ccl.net
Date: Fri Feb 1 09:37:36 2013
Subject: 13.06.19 CHI's Structure-Based Drug Design
June 19-21, 2013, The Revere Hotel, Boston, MA http://www.healthtech.com/sbd/ At CHI/Bio-IT World's thirteenth annual Structure-Based Drug Design conference, you will hear about developments in insilico technology, as well as experimental approaches useful for accurately predicting and modeling the structures of proteins in structure-based drug design efforts. In addition, examples of successful applications of such technology approaches to genome-to-drug lead investigations will be addressed. KEYNOTE PRESENTATION: Drugging the Undruggable: Transforming Nature's α-Helix into Breakthrough Medicines Tomi Sawyer, Ph.D., CSO, Aileron Therapeutics Exploiting Solvent Effects in Drug Design and Optimization Christopher R. Corbeil, Ph.D., Research Scientist, Chemical Computing Group Determination of Binding Poses, Kinetics and Energetics in Fragment-Based Design Gianni De Fabritiis, Ph.D., Computational Biophysics Laboratory (GRIB-IMIM), Universitat Pompeu Fabra, Barcelona Biomedical Research Park (PRBB) Visually Informed, Interactive Lead Optimization Carsten Detering, Ph.D., CEO, BioSolveIT Case Histories of Recent Fragment-Based Drug Discovery Projects Christopher Murray, Ph.D., Director, VP Discovery Technology, Astex Pharmaceuticals Incorporating Ligand Polarisation in Binding Free Energy Calculations Jonathan W. Essex, Ph.D., Head, Computational Systems Chemistry, Chairman, Institute for Complex Systems Simulation (ICSS), School of Chemistry, University of SouthamptonNOTE THAT E-MAIL ADDRESSES HAVE BEEN MODIFIED!!!